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Abstract
Background: There is a huge effort in developing ligand-mediated targeting of nanoparticles to diseased cells and
tissue. The plant toxin ricin has been shown to enter cells by utilizing both dynamin-dependent and -independent
endocytic pathways. Thus, it is a representative ligand for addressing the important issue of whether even a
relatively small ligand-nanoparticle conjugate can gain access to the same endocytic pathways as the free ligand.
Results: Here we present a systematic study concerning the internalization mechanism of ricinB:Quantum dot (QD)
nanoparticle conjugates in HeLa cells. Contrary to uptake of ricin itself, we found that internalization of ricinB:QDs
was inhibited in HeLa cells expressing dominant-negative dynamin. Both clathrin-, Rho-dependent uptake as well as
a specific form of macropinocytosis involve dynamin. However, the ricinB:QD uptake was not affected by siRNA-
mediated knockdown of clathrin or inhibition of Rho-dependent uptake caused by treating cells with the
Clostridium C3 transferase. RicinB:QD uptake was significantly reduced by cholesterol depletion with methyl-β-
cyclodextrin and by inhibitors of actin polymerization such as cytochalasin D. Finally, we found that uptake of ricinB:
QDs was blocked by the amiloride analog EIPA, an inhibitor of macropinocytosis. Upon entry, the ricinB:QDs co-
localized with dextran, a marker for fluid-phase uptake. Thus, internalization of ricinB:QDs in HeLa cells critically
relies on a dynamin-dependent macropinocytosis-like mechanism.
Conclusions: Our results demonstrate that internalization of a ligand-nanoparticle conjugate can be dependent on
other endocytic mechanisms than those used by the free ligand, highlighting the challenges of using ligand-
mediated targeting of nanoparticles-based drug delivery vehicles to cells of diseased tissues.
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Background
Nanomedicine is an interdisciplinary field of research fo-
cusing on the development of nanoparticles (NPs) for
clinical use in targeted drug delivery and diagnostic
in vivo imaging. The goal will often be to increase the ef-
ficacy of drugs/ siRNAs at the target tissue and reduce
the dose of drug into bystander tissue, and/or to develop
NPs into diagnostic imaging agents specifically targeting
tumors and diseased tissues. However, studies to funda-
mentally understand the mechanisms of cell-nanoparticle
interactions are still lacking. Investigating whether the
nanoparticles themselves might have adverse effects is also
of crucial importance. The small sizes of nanoparticles
enable them to cross various biological barriers of the
body and also to enter the endocytic pathways of the
cells, which in turn can give rise to unexpected toxici-
ties. In a previous study, we demonstrated that cellular
uptake of quantum dot (QD) nanocrystals that were sur-
face modified with the targeting ligands transferrin (Tf )
and ricin, perturbed normal intracellular trafficking in
cells [1,2].
There are multiple types of endocytic pathways dis-
tinguished by specific molecular regulators. The
clathrin-mediated endocytosis is by far the best studied
of these mechanisms and was for a long time believed
to be the only endocytic mechanism in addition to
phagocytosis and macropinocytosis. However, several
clathrin-independent mechanisms have been described,
including dynamin-dependent mechanisms such as the
RhoA- and caveolae-dependent, and dynamin-independent
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mechanisms such as the Cdc42-dependent and Arf6-
dependent [3,4]. Dynamin is a large GTPase that med-
iates vesicle formation by its ability to tubulate and
constrict membranes [5]. Caveolae-mediated uptake
has been among the most studied routes of dynamin
and cholesterol dependent endocytosis. In many stud-
ies uptake of nanoparticles (NPs) has been reported
to occur via caveolae-mediated endocytosis merely
based upon inhibited uptake by the pharmacological
inhibitor methyl-β-cyclodextrin (mβCD). Notably, de-
pleting the cell of cholesterol using mβCD also inhi-
bits other endocytic mechanisms, such as clathrin-
mediated endocytosis, phagocytosis and macropinocy-
tosis [6,7]. Moreover, caveolae with a diameter of only
50–100 nm are clearly too small to be responsible for
uptake of NPs larger than 100 nm. Caveolae are
present in most vascular endothelia playing an im-
portant role in transcytosis of blood-borne molecules
across the vascular endothelial cell layer, and transcy-
tosis of 10–15 nm gold NPs linked with a caveolae-
targeting ligand has been shown [8]. The belief that
internalization via caveolae would spare its cargo
from being degraded in lysosomes has also been a
reason for ‘targeting’ NPs to caveolae. However, the
previous model of caveolae giving rise to neutral
“caveosomes” has now been revised: The caveosomes
are artefacts obtained by overexpression of caveolin-1,
and a ligand taken up by caveolae will enter endo-
somes and be transported to lysosomes [9].
Although, macropinocytosis in general has been con-
sidered to be a dynamin-independent mechanism, the
‘circular dorsal ruffle’-type of macropinocytosis might in-
volve dynamin [10]. Macropinocytosis can in addition to
fluid-phase uptake also accommodate uptake of particu-
late matter such as viruses, bacteria and nanoparticles
[11,12]. Interestingly, dynamin-dependent and amiloride-
sensitive macropinocytosis-like mechanisms have been
reported for the uptake of bluetongue virus-1 and the Ebola
virus [13,14]. In endothelial cells, multimeric antibody-
nanoparticle conjugates directed against the intercellu-
lar adhesion molecule (ICAM-1) trigger internalization
of large (diameter, 100–400 nm) anti-ICAM-1 and
anti-PECAM-1 nanoconjugates by a macropinocytosis-
like mechanism that is dynamin-dependent and also
requires RhoA activation and actin reorganization
[15,16]. In a recent study, it has been shown that
endocytosis of chemokines in endothelial cell lines
occurred via a macropinocytosis-like process that was
not blocked by siRNA knock-down of PAK1 and
CtBP1, two effector proteins of the Rho family GTPase
Rac1 [17]. Furthermore, it has been found that spe-
cific splice-variants of dynamin-2 were required for
the internalization of fluid by endocytic pathways dis-
tinct from macropinocytosis [18].
Toxins such as the plant toxin ricin have for many
years been used as valuable tools to study intracellular
transport routes in cells, and also uptake of ricin coupled
to small gold NPs has been shown in Vero cells [19-22].
Ricin consists of two polypeptide moieties linked by a di-
sulfide bond. The B-moiety binds to glycolipids and gly-
coproteins with terminal galactose, and can therefore be
used as a membrane marker. Studies of ricin endocytosis
after inhibition of clathrin-dependent endocytosis by dif-
ferent methods demonstrated that ricin was still endocy-
tosed, and these studies provided some of the first
evidence for clathrin-independent endocytosis [23,24].
Moreover, ricin was still endocytosed after overexpres-
sion of the dominant negative mutant dynamin (dyn
K44A/G273D) [25], which inhibited clathrin-mediated
endocytosis of both transferrin (Tf) and epidermal
growth factor (EGF), whereas fluid phase uptake of
horse raddish peroxidase was unaffected [26]. Thus, ricin
can be internalized by clathrin and dynamin independ-
ent mechanisms in HeLa cells. These endocytic mechan-
isms still remain incompletely characterized, but
recently some of the proteins involved have been identi-
fied (for review see [3]). In a previous study, we found
the internalized ricin:QD NPs localizing to the same
early and late endosomes as ricin itself, but in contrast
to ricin which is also transported to the Golgi apparatus,
Golgi transport of the ricin:QD conjugate could not be
observed [1]. Recently, a few other studies also revealed
a change in ligand behavior after conjugation to NPs:
It has been demonstrated in pancreatic cancer cell
lines that anti-EGFR antibody-gold nanoparticle conju-
gates used different and faster endocytosis mechanisms
than the anti-EGFR antibody itself [27], and the va-
lency of TatP domains conjugated to QDs affected the
fate of the NPs [28]. Furthermore, multivalent binding
of antibodies and ligands of the PECAM-1 glycopro-
tein to NPs has been shown to trigger internalization
of the antibody-ligand nanoconjugates in endothelial
cells although the antibodies themselves were not
internalized [29].
In this study we investigated by which endocytic
mechanisms small (30 nm) ricinB:QD NP conjugates
were internalized, and identified a dynamin-dependent
macropinocytosis-like mechanism to be critically
involved.
Results and discussion
Here, we have investigated the endocytic mechanisms
responsible for internalization of ricinB:QDs, consisting
of PEGylated streptavidin-coupled QDs that were conju-
gated with biotinylated ricinB (multivalent, molar ratio
ricinB/QDs of 5), in HeLa cells. The size (hydrodynamic
diam.) of the ricinB:QDs conjugates were measured by
the Zetasizer to be 30 nm (5 nm variation between
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batches), small enough to be endocytosed by most endo-
cytic mechanisms.
Internalization of ricinB:QDs is mediated by dynamin-
dependent endocytosis that is independent of clathrin
In our study of the endocytic mechanisms involved in
uptake of ricinB:QD NP conjugates, we first investigated
whether dynamin played a role. The role of dynamin-
dependent endocytosis in uptake of ricinB:QDs was
investigated in a HeLa cell line that expresses the
dominant-negative dynamin-1 K44A mutant in a
tetracycline-inducible manner [30]. Expression of the
mutant dynamin K44A was induced by removal of tetra-
cycline (−tetracycline) from the cells for 48 h prior to
ricinB:QDs being added. Uptake of the fluorescent ricinB:
QDs was analyzed by confocal microscopy (Figure 1). In
control cells (A, +tetracycline), the ricinB:QDs were effi-
ciently internalized within 20 min and found in endoso-
mal ‘dot-like’ structures displaying a colocalization pattern
with EEA1- and CD63-positive structures. In contrast,
cells expressing the mutant dynamin K44A (B, -tetracyc-
line) showed ricinB:QDs localized at the plasma mem-
brane, and there was no significant colocalization with the
endosomal markers. Furthermore, also during live-cell im-
aging of the HeLa cells, stained with the late endosomal
(/low pH) marker LysoTracker, an inhibition in
internalization of ricinB:QD and their colocalization with
LysoTracker was observed (Figure 1B). However, after
longer times of endocytosis, weak QD signals displaying
colocalization with the endosomal markers (EEA1 and
CD63) were also observed for the mutant dynamin
expressing cells (−tet, 90 min, lower panel). Colocalization
of ricinB:QDs with the early endosomal marker EEA1 and
the lysosomal marker CD63 was quantified after increas-
ing time of endocytosis into the cells (Figure 1C). In HeLa
cells expressing mutant dynamin, no significant
internalization of ricinB:QDs (measured as fraction of cells
with EEA1 colocalization) was detected until 45 min of in-
cubation. Moreover, even after 90 min of endocytosis in
the mutant dynamin cells, a reduced uptake and transport
of ricinB:QDs into EEA1 and CD63-positive endosomes
was quantified. In contrast, the majority of control cells
displayed up to 50% colocalization with the lysosomal
marker CD63. The binding of ricinB:QDs was not sig-
nificantly affected by the expression of dynamin
K44A, and as expected the same cells displayed a
strong inhibition of transferrin uptake due to a block
in clathrin-mediated endocytosis (data not shown).
Moreover, no significant binding or uptake of the
unconjugated streptavidin-coated QDs was detected by
confocal microscopy even after 4 h of incubation
(negative control, not shown), confirming that conju-
gation of the QDs to biotinylated ricinB conferred
specific binding and uptake into the cells. All together,
our data show that dynamin is required for efficient
uptake of the ricinB:QDs in HeLa cells. However,
ricinB:QDs was also internalized slowly and ineffi-
ciently via a dynamin-independent mechanism.
In earlier studies, it has been shown that overexpres-
sion of mutant dynamin induced other compensatory
dynamin-independent endocytic mechanisms that acted
with similar kinetics in uptake of cargo such as ricin and
the fluid phase marker HRP [25,31]. However, the
ricinB:QDs can obviously not be internalized efficiently
via this compensatory mechanism.
The next step was to examine by which dynamin-
dependent mechanism the ricinB:QD bioconjugate is
endocytosed. First, we investigated the uptake in HeLa
cells expressing vector-based clathrin siRNA (Figure 2).
The transfected cells expressing clathrin siRNA did not
stain positive for clathrin, and in these cells the uptake
of fluorescently labeled transferrin was strongly inhibited
(cells outlined in white). However, these clathrin siRNA
cells did not display any significant reduction in uptake
of the ricinB:QDs as compared to the untransfected
cells. In control cells transfected with a plasmid expres-
sing a scramble siRNA, no cells without clathrin expres-
sion and inhibited internalization of Tf were observed
(data not shown). Moreover, a BHK cell line with indu-
cible expression of clathrin antisense RNA [32] also
showed normal uptake of ricinB:Qdot nanoconjugates
(data not shown).
Cholesterol-dependent internalization of RicinB:QDs is
independent of RhoA
Because endocytosis of ricinB:QDs was critically dynamin-
dependent, we further addressed whether an endocytic
mechanism regulated by the small Rho-GTPases RhoA was
involved [33]. The small GTPase RhoA also regulates
formation of actin stress fibers and may be transiently
activated during macropinocytosis [34]. To this end,
we treated HeLa cells with the cell permeable C3
transferase, which selectively inhibits the small Rho-
GTPases RhoA-B and –C [35]. HeLa Tet dynK44A
cells were pre-treated with C3 transferase for 90 min
or left untreated. Then, the cells were allowed to
internalize the ricinB:QDs for 40 min before they were
fixed for IF microscopy. The uptake of ricinB:QDs was
shown by confocal imaging as they colocalized with
endosomal markers and could be visualized inside the
cells by z-stack imaging (Figure 3). Most of the ricinB:
QDs was endocytosed within 40 min both in control
cells and in the cells treated with C3 transferase, indi-
cating that RhoA-dependent endocytic mechanisms did
not play any significant role. Usually, inhibition of
Rho-dependent endocytosis with the C3 transferase
coincides with a change in morphology where the cells
get smaller and less ‘spread out’. Here, we also observed
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a similar change in morphology of the treated cells
(Figure 3B). Furthermore, in a recent study we found that
the C3 transferase inhibited internalization of the C. botu-
linum C2 toxin in these HeLa cells [36].
Cholesterol is a critical constituent of lipid rafts and has
been reported to play an important role in various mecha-
nisms of endocytosis such as clathrin-mediated, caveolae-
mediated, flotillin-mediated and macropinocytosis [3,7].
Figure 1 Dynamin-dependent endocytosis of ricinB:QDs into HeLa cells. Expression of the dominant-negative dynamin mutant was induced
by removing tetracycline (B, -tet for 2 days), whereas control cells were grown in presence of tetracycline. All the cells were incubated with ricinB:
QDs (100 nM: 20 nM) for various times at 37°C before fixation and fluorescent antibody labeling against EEA1 (green) and CD63 (blue),
respectively. A/B: Internalization of ricinB:QDs into the HeLa, DynK44A cell line for 20 min, 30 min and 90 min. C: The kinetics of colocalization of
ricinB:QDs and the endosomal markers EEA1(blue) and CD63 (red) in control cells (+tet) and in the mutant dynamin cells (−tet, dotted line),
respectively. Quantification of the extent of colocalization between ricinB:QDs and EEA1 or CD63 (at each time point presented as percentage of
cells displaying> 20% of total ricinB:QD pixels colocalizing with EEA1 and CD63, n= 30 cells pr. time point).
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Therefore, we decided to deplete the HeLa cells for choles-
terol by pretreatment for 30 min with the inhibitor mβCD
(10 μM). The cells were then allowed to internalize ricinB:
QDs (Figure 4A,B) or ricinB-biotin:streptavidin-Cy3 conju-
gates together with Tf (Figure 4C), respectively for 30 min.
Figure 4B shows that the uptake of ricinB:QDs was strongly
reduced in cells depleted of cholesterol, since no
colocalization with the endosomal marker EEA1 was
observed and side views of the cells revealed ricinB:QD
staining of the cell surface only. This result shows the in-
volvement of cholesterol in uptake of the ricinB:QDs. Not-
ably, caveolae-mediated endocytosis is not likely to play
any important role in the uptake of ricinB:QDs, because
the HeLa dynK44A cells contain very few caveolae [37]. In
Figure 2 Clathrin independent entry of the ricinB:QDs into HeLa cells. HeLa cells were subjected to vector-based siRNA knock-down of
clathrin heavy chain for 3 days. The ricinB:QD655 bioconjugates were allowed to be internalized into the cells at 37°C for 30 min and 180 min,
respectively (representative images, upper/lower panel). Alexa555 (al555)-transferrin (Tf) (green) was added to cells for the last 20 min of the
endocytosis period. The cells were then fixed and prepared for confocal immuno-fluorescence microscopy labeling them with antibodies against
clathrin heavy-chain, EEA1 and CD63, and with the appropriate secondary antibody-Cy2 (blue)/Cy5 (white) fluorophore-conjugates. Images show
normal uptake of ricinB:QD655 in cells were clathrin is knocked down (− clathrin, no blue staining), whereas the alexa555-Tf uptake was inhibited
and only weakly stained the periphery of these cells.
Figure 3 Uptake of ricinB:QDs is not reduced by inhibition of Rho. (A) Cells were left untreated, or (B) pre-treated with C3 transferase (1 μg/ml),
followed by incubation with ricinB:QDs at 37°C for 40 min. Then, the cells were fixed and stained with the appropriate antibodies against the endosomal
marker EEA1 (blue) and CD63 (green), respectively. Images include orthogonal views generated from a z-stack of images.
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a previous study, we demonstrated that cholesterol deple-
tion by mβCD in HeLa cells only reduced endocytosis of
Tf by 50% whereas ricin uptake was reduced by< 20% [6].
Thus, as a positive control we show that the cells treated
with mβCD still internalized ricinB and Tf (Figure 4C), as
fluorescently labeled ricinB (red color) and Tf (green
color) displayed significant colocalization in endosomal
‘dots’ within the cells.
Effects of actin inhibitors on the ricinB:QD endocytosis
In order to address the role of actin filament assembly in
uptake of the ricinB:QDs, HeLa cells were pre-treated
with the inhibitor cytochalasin D (cytD, 5 μM). CytD is a
cell-membrane permeant that caps actin filaments thereby
preventing further polymerization and ultimately resulting
in actin filament disassembly. As seen in Figure 5B, up-
take of the ricinB:QDs was strongly reduced by cytD,
Figure 4 Inhibited uptake of ricinB:QDs upon cholesterol depletion. The HeLa cells were left untreated (A) or were pretreated with methyl-
β-cyclodextrin (mβCD, 10 μM) for 30 min (B and C). Then, the cells were allowed to bind and endocytose ricinB, ricinB:QDs (red), or Tf-alexa647
(green) for 30 min. The cells were fixed and stained with an antibody against EEA1 followed by the appropriate secondary ab-Cy2 (green)
conjugate or with streptavidin-Cy3 (red) conjugate to stain for the biotinylated ricinB.
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as most ricinB:QDs were localized along the cell per-
iphery. Uptake of Tf-al555 was not significantly inhib-
ited by cytD and displayed colocalization with EEA1
(blue) in endosomal ‘spots’.
In contrast to our findings, endocytosis of small parti-
cles such as QDs (<100 nm) have been reported to be
insensitive to cytD in mammalian macrophages, leuko-
cytes and dendritic cells [38,39]. However, disruption of
F actin by cytD has been reported to play a variable role
in endocytosis of Tf depending on both the cell line and
whether the cells were grown in suspension or not
[40,41]. Recently, is has been shown that membrane ten-
sion can decide whether actin is required for clathrin-
dependent endocytosis [41].
Internalization of ricinB:QDs is mediated by a
macropinocytosis-like mechanism
Macropinocytosis is known to be critically dependent on
the actin cytoskeleton for generating the plasma mem-
brane ‘ruffles’ or filopodia that fold back on the plasma
membrane to form the macropinosomes. Macropinocy-
tosis is dependent upon the amiloride-sensitive Na+/H+
exchanger in the plasma membrane and is inhibited by
5-(N-ethyl-N-isopropyl)-amiloride (EIPA). In a recent
study it has been shown that the inhibitory effects of
amiloride and related compounds are the consequence
of submembranous acidification caused by H+ gener-
ation and the blocked Na+/H+ exchange across the
plasma membrane [42]. The macropinosomes that
pinches off from the cell surface can be identified
through the use of fluid phase markers such as dextran,
horse radish peroxidase and Lucifer Yellow. Upon co-
internalization of ricinB:QDs and dextran, we observed
good co-localization between them within endosomal
structures (yellow color) even after short times of
internalization (< 30 min., Figure 6A), indicating that
they were endocytosed by the same mechanism. To as-
certain that this colocalization was not an artifact due to
cross-talk of the QD signal into the dextran-alexa594
channel, we showed that the dextran signal within the
rectangle area (Figure 6A, inset shows pre-bleech) could
be photo-bleached using high laser power whereas the
QD signal persisted. Furthermore, we observed an in-
creasing colocalization between ricinB:QDs and the lyso-
somal marker CD63 from 30 min to 90 min (shown as
purple color, Figure 6A,C insets), indicative of routing of
the ricinB:QDs into lysosomes/late endosomes. Import-
antly, Figure 6 (B and D) shows that EIPA efficiently
inhibited uptake of the ricinB:QDs and dextran in HeLa
cells. In the EIPA-treated cells, the ricinB: QDs were still
retained at the cell surface after 90 min of endocytosis.
In contrast, EIPA did not inhibit uptake of transferrin as
most EIPA-treated cells showed Tf uptake (not shown).
The activation of PI3K and the engagement of signal-
ing molecules including Rac1, Arf6 and the RhoA
GTPase are common to a variety of actin-dependent
Figure 5 Actin-dependent uptake of the ricinB:QDs. HeLa cells were left untreated (A) or treated with cytD (B). Then, ricinB:QDs (in red) and
transferrin- alexa555 (Tf-al555, green) were endocytosed for 30 min at 37°C. The cells were fixed and stained with an anti-EEA1 antibody and the
appropriate secondary antibody-Cy2 conjugate (blue) together with phalloidin (Ph)-alexa647 (white) for staining of actin. The cell nuclei were
stained with Hoechst33342 (white).
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processes such as phagocytosis and macropinocytosis
[43]. In this context, it is interesting to note that in this
study uptake of ricinB: QDs were not inhibited by treat-
ment of the HeLa cells with the inhibitor of Rho, C3
transferase (see Figure 3). Furthermore, overexpression
of the dominant-negative mutant Arf6 T27N in a stably
transfected HeLa cell line [44] did not inhibit endocyto-
sis of ricinB: QDs (data not shown). Macropinocytosis
has been considered as a regulated form of endocytosis
induced in response to growth factors such as epidermal
growth factor [45]. Therefore, we would like to know
whether the ricinB: QDs could induce such a fluid phase
pathway. Using the Olympus ScanR fluorescence
microscope, we quantified the uptake of fluorescent
dextran-alexa594 in HeLa cells when taken up alone or
when co-internalized with the ricinB:QDs for 30 min. No
differences in the fluorescence intensities of internalized
dextran were measured between the two conditions (data
Figure 6 Inhibition of ricinB:QDot endocytosis upon treatment of cells with EIPA, an inhibitor of macropinocytosis. RicinB: QDs (red)
were pre-bound to HeLa cells at 4°C, and then internalized in the presence of alexa594 dextran (green) for 30 min (panel A,B) and 90 min (panel C,D),
respectively. The cells were fixed and stained with lysosomal antibody CD63 and its corresponding secondary antibody-Cy2 (blue). The cell nuclei were
stained with Hoechst33342 (white).
Iversen et al. Journal of Nanobiotechnology 2012, 10:33 Page 8 of 11
http://www.jnanobiotechnology.com/content/10/1/33
not shown), indicating that uptake of the ricinB:QDs did
not significantly change the fluid uptake of dextran dur-
ing this time period.
Conclusions
In this study we investigated the relevance of various
endocytic pathways in the uptake of ricin-coupled QD
nanoparticles conjugates in HeLa cells. We demon-
strated that the ricin-QDs conjugates were endocytosed
by a dynamin-dependent but clathrin-independent path-
way. Furthermore, treatment of the cells with C3 trans-
ferase to inhibit the Rho-mediated endocytic mechanism
did not affect ricinB:QD uptake. Depletion of cholesterol
from the cells, significantly reduced the uptake of ricinB:
QDs. Interestingly, treatment of the cells with an inhibi-
tor of macropinocytosis, the amiloride-analog EIPA,
strongly reduced the uptake of ricinB: QDs. Thus, we
have demonstrated that a dynamin-dependent and
macropinocytosis-like pathway is necessary for the effi-
cient endocytosis of ricinB:QD nanoconjugates. In con-
trast, ricin alone is internalized equally efficiently both
by dynamin-dependent and dynamin-independent endo-
cytic pathways. These endocytic pathways seem to be
unavailable for internalization of the ricinB:QDs, and
their uptake is instead triggered via a specific endocytic
pathway (Figure 7). These results demonstrate that one
needs to be cautious when ligands are coupled to nano-
particles with the intention of achieving efficient NP de-
livery into certain cells or tissues by a given endocytic
mechanism. Clearly, the endocytic pathways operating
after nanoconjugation warrants further investigations.
The size of the NPs to which the ligands are conjugated
is certainly also an issue, as larger NPs cannot enter into
some endocytic pathways due to sterical hindrance. Im-
portantly, the multivalency of ligand-nanoparticle conju-
gates might not only increase the affinity for a cell, but
also enable more efficient receptor clustering resulting
in induction of signaling and thereby triggering of alter-
native endocytic pathways.
Methods
Experimental reagents
Reagents used in this study included the amiloride ana-
loge EIPA (Sigma), cytochalasin D (Sigma), methyl-β-
cyclodextrin (Sigma), ADP-ribosyltranferase C3 (Sigma).
RicinB subunit was purchased from Vector Laboratories
(Burlingame, CA). Quantum dots 655 nm, alexa-555
transferrin (Tf), alexa-594 dextran, alexa-647 phalloidin
(Ph), and Hoechst 33342 were purchased from Invitro-
gen (Carlsbad, CA). The following antibodies were used:
Rabbit anti-EEA1 (Cell Signaling Technologies), mouse
anti-CD63 (Developmental Studies Hybridoma Bank,
Univ. of Iowa). The Cy2- and Cy3-labeled secondary
antibody conjugates of donkey anti-rabbit and donkey
anti-mouse were purchased from Jackson ImmunoRe-
search Laboratories (West Grove, PA, USA).
Biotinylation of ricinB
RicinB (1 mg/ml) was biotinylated according to manu-
facturer’s instructions using NHS-SS-biotin (Pierce,
Rockford, IL) in a 1:20 molar ratio of ricin:biotin. The
reaction took place at room temperature in the dark for
45 min. Unincorporated NHS-SS-biotin was removed
using a spin column (Micron, YM-10, Millipore).
Hydrodynamic size measurement
The hydrodynamic diameter of the streptavidin-coupled
QD655 particles was measured in PBS buffer or in
cell culture medium using using a Zetasizer Nano ZS
(Malvern Instruments Ltd, Worcestershire, UK).
Cell culture
HeLa cells were maintained at 37°C and 5% CO2 in
Dulbecco’s Modified Eagle medium, DMEM (Invitrogen,
Figure 7 Endocytosis of ricinB:QD nanocomplexes is restricted to a macropinocytosis-like pathway. Ricin:QD NPs cannot exploit the
various endocytic pathways accessible to ricin toxin itself.
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Carlsbad, CA, USA), supplemented with 10% v/v fetal bo-
vine serum (PAA Laboratories, Linz, Austria), 100 U/ml
penicillin (Invitrogen) and 100 μg/ml streptomycin
(Invitrogen).
Cellular uptake of ricinB:qdot nanoconjugates by confocal
fluorescence microscopy
HeLa cells or HeLa Dyn-K44A cells (seeded 2x104cells/
well in 24-well trays) were cultured on coverslips for
24 h or 48 h prior to the experiments, respectively.
Then, ricinB:QDs conjugates were prepared directly at
the cell surface, as previously described:[1] Cells were
washed in cold Hepes-medium prior to incubation with
the biotinylated ricinB (200 nM) ligand in Hepes
medium for 10 min on ice. The cells were briefly washed
2x in tetra-borate buffer (50 mM sodium-borate, pH8.3;
215 mM sucrose) and then incubated with the
streptavidin-coupled QD655 (20 nM) in tetra-borate
buffer for 5 min on ice [46]. Subsequently, the cells were
washed 2x in Hepes medium before endocytosis of the
ricinB:QDs (molar ratio, 5:1) was performed by incubat-
ing the cells in Hepes medium at 37C for various times
with or without the appropriate inhibitors. The ricinB:
QDs were also co-internalized with other ligands such as
Tf-alexa-555 and dextran-alexa-647.
After fixation in 10% (w/v) formalin for 15 min, the
cells were permeabilized and blocked in 0.1% Triton
X-100 and 1% BSA in PBS for 1 hour at room
temperature. The cells were immuno-stained with the
following primary antibodies: mouse anti-EEA1 ab.
(1:100) and mouse anti-CD63 ab. (1:200). The second-
ary antibody-fluorescent dye conjugates used were:
Donkey anti-rabbit-Cy2 (1:200), donkey anti-rabbit-
Cy3 (1:500) and donkey anti-mouse-Cy2 (1:500). Cov-
erslips were mounted in Mowiol (Calbiochem) and
examined using a confocal microscope (LSM 788; Carl
Zeiss MicroImaging, Inc.) equipped with a Neo-Fluar
63x/1.45 oil immersion objective. Image processing
and analysis were done with Zeiss LSM 510 software
version 3.2 and Adobe Photoshop 7.0.
Vector-based siRNA knock-down of clathrin
Clathrin heavy-chain was knocked down with a vector-
based siRNA construct [47]. Cells were transiently trans-
fected for 3 days with plasmid DNA using Fugene 6
(Roche Diagnostics, Mannheim, Germany), according to
the manufacturer’s protocol.
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